Posted in | News | Quantum Dots | Quantum Optics

QD Vision Announces New Investments to Address Increasing Demand for Color IQ™ Quantum Dot Technology

QD Vision today announced significant new investments to meet surging demand for its Color IQ™ quantum dot technology for televisions and monitors. The new funding will help accelerate the growth of the company, particularly by expanding sales and marketing operations in China – the global center of TV manufacturing and consumption.

The new funding will also be used to expand QD Vision’s product portfolio by extending its leading-edge color technologies to the fullest range of hardware and content platforms.

QD Vision also announced the appointment of Steve Ward as the company’s Executive Chairman, with responsibility for driving global strategy and operations. Mr. Ward, who served as a member of QD vision’s Board of Directors, was previously the CEO of Lenovo, the international company formed by the merger of Lenovo of China and IBM’s PC business. Mr. Ward also has significant experience in building successful global technology businesses, including IBM and numerous startups.

“Today’s announcements underscore our confidence that 2015 is the year QD Vision brings the world’s best color to the mainstream,” said Seth Coe-Sullivan, Founder and Chief Technology Officer of QD Vision. “Under Steve Ward’s leadership, our company is well-positioned to deliver the world’s best color to a broad audience on a global scale.”

“QD Vision is a clear technology leader in an exciting new category that is about to explode,” said Steve Ward, newly appointed Executive Chairman of QD Vision. “I am honored to be given this opportunity to help the company bring its unique and valuable contributions to market.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.